GLD 40 Pill - brown capsule/oblong

Pill with imprint GLD 40 is Brown, Capsule/Oblong and has been identified as Doxycycline (Anhydrous) Immediate/Delayed Release 40 mg (immediate release 30 mg / delayed release 10 mg). It is supplied by Owen Laboratories, Inc.

Doxycycline is used in the treatment of Acne; Actinomycosis; Amebiasis; Anthrax; Gonococcal Infection, Uncomplicated and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 40 mg (immediate release 30 mg / delayed release 10 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for GLD 40

Doxycycline (Anhydrous) Immediate/Delayed Release

Imprint: GLD 40
Strength: 40 mg (immediate release 30 mg / delayed release 10 mg)
Color: Brown
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Miscellaneous antimalarials, Tetracyclines
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Owen Laboratories, Inc.
Inactive Ingredients: hypromelloses, ferric oxide red, ferric oxide yellow, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, polysorbate 80, sucrose, magnesium silicate, titanium dioxide, triethyl citrate
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
69007-0822 (Discontinued)
00299-3822	Galderma Laboratories, L.P.
66993-0815	Prasco Laboratories
54868-5676 (Discontinued)	Physicians Total Care Inc. (repackager)